What is Haemonetics's PP&E (net)?

Haemonetics (HAE) reported PP&E (net) of $305.76M in Q1 2026.

How has Haemonetics's PP&E (net) changed year-over-year?

Haemonetics's PP&E (net) increased by 7.6% year-over-year, from $284.05M to $305.76M.

What is the long-term trend for Haemonetics's PP&E (net)?

Over 5 years (2021 to 2026), Haemonetics's PP&E (net) has grown at a 7.0% compound annual growth rate (CAGR), from $217.56M to $305.76M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Haemonetics HAE PP&E (Net)

PP&E (Net) at other companies

AbbottABT

$12.38B+13.2%

TFX

TeleflexTFX

$476.96M-8.1%

Boston ScientificBSX

$4.06B+19.9%

MedtronicMDT

$7.42B+8.5%

LivaNovaLIVN

$255.48M+43.8%

ICU MedicalICUI

$445.14M+0.7%

Segments

By segment

See full

Plasma$206.37M+8.7%

Hospital$59.72M+10.8%

Blood Center$39.68M-1.6%

By geography

See full

Europe$32.08M+60.2%

Rest of Asia$30.83M+7.4%

Other$17.23M+2.2%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's PP&E (net)?: Haemonetics (HAE) reported PP&E (net) of $305.76M in Q1 2026.
How has Haemonetics's PP&E (net) changed year-over-year?: Haemonetics's PP&E (net) increased by 7.6% year-over-year, from $284.05M to $305.76M.
What is the long-term trend for Haemonetics's PP&E (net)?: Over 5 years (2021 to 2026), Haemonetics's PP&E (net) has grown at a 7.0% compound annual growth rate (CAGR), from $217.56M to $305.76M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.